ArticleVaccine: X2023

Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis.

David Hakimian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.